Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICStandard

BIMATOPROST

BIMATOPROST

Standard Dose
0.03%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview BIMATOPROST is listed in Drugs@FDA under application 210263 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient BIMATOPROST Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.03% Sponsor ALEMBIC Submission history Latest submission status date: 2022-12-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview BIMATOPROST is listed in Drugs@FDA under application 210263 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient BIMATOPROST Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.03% Sponsor ALEMBIC Submission history Latest submission status date: 2022-12-20 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.